AREV Life Sciences Global Corp. AREV Life Sciences Global Corp.

AREV Life Sciences Global Corp.

AREV

Classement en actions #36944
AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005,... AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005, operates as an integrated life science discovery firm, focusing on the development and sale of functional ingredients throughout Canada. Its diverse product line includes various CBD-infused items like the anti-viral supplements Canna-Mulsion and NaturVax, NaturRelax for natural sleep support, and Natur Relief, designed for anti-inflammatory and pain relief. Additionally, the company provides white-label cannabis products, a selection of THC offerings, cannabis-based skincare, and medicinal oils and edibles. These specialized ingredients are utilized in products intended for the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical industries. AREV's solutions target health concerns such as sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, alongside other specific ailments. The company also offers nutraceutical formulations under its Bare brand and ready-to-use therapeutic food products named SUS-TAINN. Formerly known as AREV NanoTec Brands Inc., the company officially adopted its current name in August 2021.
Prix de l'action
$0.06605432
Dernière synchronisation: 2024-07-23
Capitalisation boursière
$2.08M
Changement (1 jour)
-2.93%
Changement (1 an)
560.54%
Pays
CA
Échange AREV Life Sciences Global Corp. (AREV)

Catégorie

Healthcare
Historique des divisions d’actions pour AREV Life Sciences Global Corp. (AREV)
L’action AREV Life Sciences Global Corp. (symbole : AREV) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action AREV achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions AREV.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes